Search
forResearch 10 of 1000+
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Poly (lactic-co-glycolic acid)-based microneedles for drug delivery across different biological barriers
- Adverse Effects and Drug Interactions of Biologic Agents
- Drug delivery to the hair follicle : role of follicular tight junctions as a biological barrier and the potential for targeting clobetasol nanocarriers
- Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents
- KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Photo-responsive fibers as artificial hairs in an in-vitro model for transdermal drug delivery
Community 3 of 11
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
- Why hasn’t anyone made a "DHT sponge" biologic yet???
- 42 male - 8 months (Is this the biological limit?)